Soft tissue sarcomas (STS) are highly fluorine-18-fluorodeoxyglucose (F-FDG)-avid tumours. PET seems to be effective for the assessment of the extent of disease. However, the use of PET to stratify STS into different risk histotypes still remains controversial. Our aim was to evaluate F-FDG uptake in different STS types and to assess the prognostic value of the maximum standardized uptake value (SUVmax).
Sambri, A., Bianchi, G., Longhi, A., Righi, A., Donati, D.M., Nanni, C., et al. (2019). The role of 18F-FDG PET/CT in soft tissue sarcoma. NUCLEAR MEDICINE COMMUNICATIONS, 40(6), 626-631 [10.1097/MNM.0000000000001002].
The role of 18F-FDG PET/CT in soft tissue sarcoma
Sambri, Andrea
;Righi, Alberto;Donati, Davide Maria;Nanni, Cristina;Fanti, Stefano;Errani, Costantino
2019
Abstract
Soft tissue sarcomas (STS) are highly fluorine-18-fluorodeoxyglucose (F-FDG)-avid tumours. PET seems to be effective for the assessment of the extent of disease. However, the use of PET to stratify STS into different risk histotypes still remains controversial. Our aim was to evaluate F-FDG uptake in different STS types and to assess the prognostic value of the maximum standardized uptake value (SUVmax).File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
